EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease

Agustin Hidalgo-Gutierrez iD, Jonathan Shintaku iD, Javier Ramon iD, Eliana Barriocanal-Casado iD, Alba Pesini iD, Russell P Saneto iD, Gloria Garrabou iD, Jose Cesar Milisenda iD, Ana Matas-Garcia, Laura Gort iD, Olatz Ugarteburu iD, Yue Gu und 16 weitere

Annals of Neurology · 2024

DOI: 10.1002/ana.27071 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Neurology, 2024. Verfasst von Agustin Hidalgo-Gutierrez und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Columbia University Irving Medical Center, New York, NY. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitochondrial Diseases, Guanylate Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shuman Mitochondrial Disease Fundation, JDM Fund for mitochondrial research, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SEQMD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mitochondrial DNA (mtDNA) depletion/deletions syndrome (MDDS) comprises a group of diseases caused by primary autosomal defects of mtDNA maintenance. Our objective was to study the etiology of MDDS in 4 patients who lack pathogenic variants in known genetic causes.

Methods

Whole exome sequencing of the probands was performed to identify pathogenic variants. We validated the mitochondrial defect by analyzing mtDNA, mitochondrial dNTP pools, respiratory chain activities, and GUK1 activity. To confirm pathogenicity of GUK1 deficiency, we expressed 2 GUK1 isoforms in patient cells.

Results

We identified biallelic GUK1 pathogenic variants in all 4 probands who presented with ptosis, ophthalmoparesis, and myopathic proximal limb weakness, as well as variable hepatopathy and altered T‐lymphocyte profiles. Muscle biopsies from all probands showed mtDNA depletion, deletions, or both, as well as reduced activities of mitochondrial respiratory chain enzymes. GUK1 encodes guanylate kinase, originally identified as a cytosolic enzyme. Long and short isoforms of GUK1 exist. We observed that the long isoform is intramitochondrial and the short is cytosolic. In probands’ fibroblasts, we noted decreased GUK1 activity causing unbalanced mitochondrial dNTP pools and mtDNA depletion in both replicating and quiescent fibroblasts indicating that GUK1 deficiency impairs de novo and salvage nucleotide pathways. Proband fibroblasts treated with deoxyguanosine and/or forodesine, a purine phosphatase inhibitor, ameliorated mtDNA depletion, indicating potential pharmacological therapies.

Interpretation

Primary GUK1 deficiency is a new and potentially treatable cause of MDDS. The cytosolic isoform of GUK1 may contribute to the T‐lymphocyte abnormality, which has not been observed in other MDDS disorders. ANN NEUROL 2024;96:1209–1224

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialMitochondrial DiseasesGuanylate KinasesAdultChildFemaleHumansMaleExome SequencingFibroblasts

Substanzen

DNA, MitochondrialGuanylate Kinases

Autor:innen und Institutionen

  • Department of Neurology, Columbia University Irving Medical Center, New York, NY.
  • Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Vall d'Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.
  • Seattle Children's Hospital, Seattle, WA.
  • Inherited Metabolic Diseases and Muscle Disorder's Lab, Cellex - IDIBAPS, Faculty of Medicine and Health Science - University of Barcelona (UB), Barcelona, Spain.
  • Department of Internal Medicine, Hospital Clínic of Barcelona, Barcelona, Spain.

ORCID-Profile: Agustin Hidalgo-Gutierrez, Jonathan Shintaku, Javier Ramon, Eliana Barriocanal-Casado, Alba Pesini, Russell P Saneto, Gloria Garrabou, Jose Cesar Milisenda, Laura Gort, Olatz Ugarteburu, Megi Meneri, Monica Sciacco, Shuang Wang, Kurenai Tanji, Marshall S Horwitz, Mahesh Mansukhani, Giacomo Pietro Comi, Dario Ronchi, Ramon Marti, Antonia Ribes, Frederic Tort, Michio Hirano

Förderung

  • Shuman Mitochondrial Disease Fundation
  • JDM Fund for mitochondrial research
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SEQMD
  • Common Fund
  • NINDS NIH HHS
  • Wellcome Trust
  • NICHD NIH HHS
  • Instituto de Salud Carlos III

Zitieren

APA

Hidalgo-Gutierrez, A., Shintaku, J., Ramon, J., Barriocanal-Casado, E., Pesini, A., Saneto, R. P., Garrabou, G., Milisenda, J. C., Matas-Garcia, A., Gort, L., Ugarteburu, O., Gu, Y., Koganti, L., Wang, T., Tadesse, S., Meneri, M., Sciacco, M., Wang, S., Tanji, K., …, & Hirano, M. (2024). Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease. Annals of Neurology. https://doi.org/10.1002/ana.27071

Vancouver

Hidalgo-Gutierrez A, Shintaku J, Ramon J, Barriocanal-Casado E, Pesini A, Saneto RP, et al. Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease. Annals of Neurology. 2024. doi:10.1002/ana.27071

BibTeX
@article{HidalgoGutierrez2024,
  author = {Hidalgo-Gutierrez, Agustin and Shintaku, Jonathan and Ramon, Javier and Barriocanal-Casado, Eliana and Pesini, Alba and Saneto, Russell P and Garrabou, Gloria and Milisenda, Jose Cesar and Matas-Garcia, Ana and Gort, Laura and Ugarteburu, Olatz and Gu, Yue and Koganti, Lahari and Wang, Tian and Tadesse, Saba and Meneri, Megi and Sciacco, Monica and Wang, Shuang and Tanji, Kurenai and Horwitz, Marshall S and Dorschner, Michael O and Mansukhani, Mahesh and Comi, Giacomo Pietro and Ronchi, Dario and Marti, Ramon and Ribes, Antonia and Tort, Frederic and Hirano, Michio},
  title = {Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease},
  journal = {Annals of Neurology},
  year = {2024},
  doi = {10.1002/ana.27071}
}
Kostenlos starten →